Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fast And Furious: Lessons From China FDA's Innovation Push

This article was originally published in SRA

Executive Summary

Last July, when the China Food and Drug Administration's commissioner Bi Jingquan gave a speech during a ceremony at Peking University's Pharmaceutical Engineering Management class, no one realized that it marked the start of a new era of drug regulation in the country.


Related Content

China Regulatory Shakeup: Top Regulator Out, Commissioner Reprimanded Amid Vaccine Scandal
2016 Review: Rapid Change Defines China Regulatory Environment
China Regulatory Watch: New Fast-Track Designations, CTAs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts